Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement

Prospective, Multicentric, Observational Cohort Study for the Evaluation of Implant Survival in Patients With a Metal-on-Metal Pinnacle(R) Ultamet(TM) Device in Conventional Total Hip Joint Replacement.

The objective is to evaluate the implant survival rate for patients implanted with a PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the treatment of a severe hip disease and true femoral cervical fracture.

Inclusion Criteria:

• Patients susceptible to receive a PINNACLE® ULTAMET™ implant as per routine practice

Exclusion Criteria:

• Patient refusal to participate to the data collection
• Pregnant woman
• Patients age is less than 18 years old
• The planned intervention is a revision of a previous intervention on the studied hip joint
• Previous metal implant, except for pure titanium or titanium alloys
• Exposure to cobalt and chromium that could influence serum metal ions levels
• Planned bilateral intervention
• Patient residing outside France
• Patient not implanted with a Pinnacle(R) ULTAMET(TM)